| scholarly article | Q13442814 |
| case report | Q2782326 |
| P2093 | author name string | Donald G Murphy | |
| Cécile L Tremblay | |||
| Erwin Sablon | |||
| Eric Fournier | |||
| Raymond Dandavino | |||
| Jasmine Chamberland | |||
| P2860 | cites work | The neighbor-joining method: a new method for reconstructing phylogenetic trees | Q25939010 |
| euHCVdb: the European hepatitis C virus database | Q27477695 | ||
| Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay | Q27478358 | ||
| Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5' Untranslated Region Sequences | Q27478359 | ||
| Second-generation line probe assay for hepatitis C virus genotyping | Q27485722 | ||
| Global epidemiology of hepatitis C virus infection | Q27860799 | ||
| MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods | Q27860929 | ||
| Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes | Q27861119 | ||
| Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination | Q29616724 | ||
| Unravelling hepatitis C virus replication from genome to function | Q29620056 | ||
| Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource | Q33777199 | ||
| Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa | Q34172845 | ||
| An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region | Q34238283 | ||
| Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems. | Q34288777 | ||
| Phylogeography and molecular epidemiology of hepatitis C virus genotype 2 in Africa | Q34983357 | ||
| Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor | Q37335699 | ||
| Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. | Q42984512 | ||
| The Los Alamos hepatitis C sequence database | Q42987686 | ||
| The hepatitis C virus epidemic in Cameroon: genetic evidence for rapid transmission between 1920 and 1960. | Q43034111 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| P304 | page(s) | 967-972 | |
| P577 | publication date | 2014-12-17 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Hepatitis C virus genotype 7, a new genotype originating from central Africa | |
| P478 | volume | 53 |
| Q56955337 | 5' UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, Egypt |
| Q92964702 | A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor |
| Q47607535 | An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots |
| Q40784168 | Analysis of HCV-6 isolates among Asian-born immigrants in North America reveals their high genetic diversity and a new subtype |
| Q88881179 | Association of TNF-α and CCL5 with response to interferon-based therapy in patients with HCV 1 genotype |
| Q92087119 | Comparative Analysis of Electrochemiluminescence Assay and Chemiluminescent Microparticle Immunoassay for the Screening of Hepatitis C |
| Q36118779 | Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India. |
| Q64954537 | Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes |
| Q39151677 | Current therapy for chronic hepatitis C: The role of direct-acting antivirals |
| Q60046649 | Distribution of HCV genotypes in Belgium from 2008 to 2015 |
| Q56395674 | Epidemic history of hepatitis C virus genotypes and subtypes in Portugal |
| Q90955086 | Epidemiología, consumo de recursos y costos del manejo médico de la Hepatitis C en Argentina, Colombia, Uruguay y Venezuela |
| Q52346277 | Evaluation of the cobas® GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures. |
| Q59350180 | Evolutionary biology of human hepatitis viruses |
| Q56492814 | Genetic Diversity of Hepatitis C Virus Among Blood Donors and Patients with Clinical Hepatitis in Ibadan, Nigeria |
| Q33752089 | Genetic diversity of hepatitis C virus in Ethiopia |
| Q30395543 | Geographic integration of hepatitis C virus: A global threat |
| Q47274792 | Global elimination of hepatitis C virus infection: Progresses and the remaining challenges |
| Q47137246 | Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity |
| Q45325157 | Hepatitis C Virus Genie: A Web 2.0 Interpretation and Analytics Platform for the Versant Hepatitis C Virus Genotype Line Probe Assay Version 2.0. |
| Q38812607 | Hepatitis C Virus Infection in Chronic Kidney Disease |
| Q47260983 | Hepatitis C Virus: Viral Quasispecies and Genotypes |
| Q30378509 | Hepatitis C treatment: where are we now? |
| Q57030951 | Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir |
| Q90266685 | Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria |
| Q45325441 | Hepatitis C virus genotypes and subtypes circulating in Mainland China |
| Q92353675 | Hepatitis C virus infection and new treatment strategies |
| Q47251889 | Hepatitis C virus: Enslavement of host factors. |
| Q92856183 | Humanized Mouse Models for the Study of Hepatitis C and Host Interactions |
| Q40109763 | Improving Metabolic Stability with Deuterium: The Discovery of BMT-052, a Pan-genotypic HCV NS5B Polymerase Inhibitor |
| Q45325504 | In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir |
| Q47336884 | Keeping Pace with the Red Queen: Identifying the Genetic Basis of Susceptibility to Infectious Disease. |
| Q47547637 | Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon. |
| Q50059408 | Molecular evolution of hepatitis C virus in China: A nationwide study |
| Q58616344 | New highly diverse hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments |
| Q64232429 | Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in Nigeria |
| Q58701132 | Pooled Resistance Analysis in Patients with Hepatitis C Virus Genotype 1 to 6 Infection Treated with Glecaprevir-Pibrentasvir in Phase 2 and 3 Clinical Trials |
| Q30241881 | Reinventing HCV Treatment: Past and Future Perspectives |
| Q40895917 | Synthesis and Structure-Activity Relationships of Imidazole-Coumarin Conjugates against Hepatitis C Virus |
| Q40675418 | Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir |
| Q92332168 | Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa |
Search more.